ASND — Ascendis Pharma A/S Ordinary Share price, chart and key statistics

Price data

Price

$227.87

Change YTD

+6.86%

Next earnings

Nov 11, 2026

Market cap

14.1B2016-12 481M2026-10 14.1B+2835.9% over the window

Enterprise value

14.4B

Shares outstanding

62M2015-12 23.8M2025-12 62M+160.8% over the window

52W low

$186.05

52W high

$282.15

From 52W high

-19.24%

From 52W low

+22.48%

52W range

44%

Beta

0.33

Volume

Rel volume

0.84×

30D volume

766.6K

30D $ vol

187.3M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.

none

Insider net 1M0 insider-days of buying (no priced lot) and 1 of selling ($811K) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$811K

Insider net 3M1 insider-day of buying ($493K) and 2 of selling ($873K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$380K

Insider net 1Y5 insider-days of buying ($777K) and 3 of selling ($5.5M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$4.7M

Form 4 transactions by trade date, as filed; latest on file 2026-09-08.

Fundamentals

Sales (ttm)

814.8M2015-12 9M2025-12 814.8M+8939.6% over the window

Sales/share

$13.152015-12 $0.382025-12 $13.15+3366.4% over the window

EPS (ttm)

-$4.252015-12 -$1.542025-12 -$4.25+175.6% over the window

FCF (ttm)

61M

FCF/share

$0.98

Book value/share

-$3.092015-12 $5.532025-12 -$3.09-155.8% over the window

Net margin

-31.67%2015-12 -405.5%2025-12 -31.7%-92.2% over the window

ROA

-16.86%2016-12 -37.7%2025-12 -16.9%-55.3% over the window

Current ratio

1.042016-12 13.672025-12 1.04-92.4% over the window

Growth (CAGR, ttm) · 10Y

Sales

+107.18%2024-12-31 → 2025-12-31393.5M → 814.8M (+107.1% total)+147.36%2022-12-31 → 2025-12-3153.8M → 814.8M (+1414.5% total)+152.61%2020-12-31 → 2025-12-317.9M → 814.8M (+10180.0% total)+56.89%2015-12-31 → 2025-12-319M → 814.8M (+8939.6% total)

Shares

+2.12%2024-12-31 → 2025-12-3160.7M → 62M (+2.1% total)+2.74%2022-12-31 → 2025-12-3157.2M → 62M (+8.4% total)+2.89%2020-12-31 → 2025-12-3153.8M → 62M (+15.3% total)+10.06%2015-12-31 → 2025-12-3123.8M → 62M (+160.8% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+102.87%2024-12-31 → 2025-12-31$6.48 → $13.15 (+102.8% total)+140.77%2022-12-31 → 2025-12-31$0.94 → $13.15 (+1296.6% total)+145.52%2020-12-31 → 2025-12-31$0.15 → $13.15 (+8815.4% total)+42.55%2015-12-31 → 2025-12-31$0.38 → $13.15 (+3366.4% total)

Price

+13.39%2025-10-02 → 2026-10-02$200.97 → $227.87 (+13.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+35.72%2023-10-02 → 2026-10-02$91.13 → $227.87 (+150.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.03%2021-10-01 → 2026-10-02$162.25 → $227.87 (+40.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+27.47%2016-09-30 → 2026-10-02$20.10 → $227.87 (+1033.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+13.39%2025-10-02 → 2026-10-02$200.97 → $227.87 (+13.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+35.72%2023-10-02 → 2026-10-02$91.13 → $227.87 (+150.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.03%2021-10-01 → 2026-10-02$162.25 → $227.87 (+40.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+27.47%2016-09-30 → 2026-10-02$20.10 → $227.87 (+1033.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-53.6×2016-12 -13.162026-10 -54.74+316.0% over the window

Fwd P/E

20.7×

P/S (ttm)Market cap ÷ TTM revenue.

17.3×2016-12 53.372026-10 17.33-67.5% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-73.8×2016-12 3.662026-10 -73.84-2118.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

231.6×

EV/Sales (ttm)

17.6×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

0.43%

Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 62.0M ÷ 60.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-2.12%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.12%) + dividends paid over that year ($0) ÷ market_cap_at(2024-12-31) ($8.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-2.12%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($19.7M) ÷ today's market cap ($14.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.14%2016-12 -29.0%2025-12 0.1%-100.5% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $19.7M + TTM dividends $0) ÷ today's market cap ($14.1B). Same caveat as the cash buyback yield.

0.14%2016-12 -29.0%2025-12 0.1%-100.5% over the window

Vs own 10Y history

P/S

3rd

P/B

100th